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INTRODUCTION
Eating disorders (EDs), such as anorexia
nervosa (AN), bulimia nervosa (BN), and
binge eating disorder (BED) are charac-
terized by pathological eating behaviors
and body image disturbance. These dis-
orders are associated with high levels of
mortality and morbidity, as well as sig-
nificantly impaired quality of life (Arcelus
et al., 2011). EDs are often associated with
young adulthood, with the disorder typi-
cally being first diagnosed when the person
is 15–19 years old (Hoek and van Hoeken,
2003; Hudson et al., 2007). Recently, there
has been increased interest in the neurobi-
ology of EDs as an insight into the mecha-
nisms of pathological eating behavior, and
as a potential avenue for treatment (Kaye
et al., 2010).
Brain-based interventions for EDs have
in the past involved highly invasive deep-
brain stimulation (DBS), in which surgi-
cally implanted electrodes deliver electrical
pulses to brain areas such as the cingulate
cortex (Israel et al., 2010) or the nucleus
accumbens (Wu et al., 2013). These surg-
eries have proved reasonably effective in the
small number of reported cases. However
DBS has a number of problems that make
it less attractive as a treatment option: DBS
exposes the person to the risks of surgery;
the potential side-effects are more serious;
and it is difficult to adjust or to reverse the
treatment. For these reasons, there is much
interest in a treatment that modulates brain
activity but that does not expose the patient
to such serious side-effects.
There has recently been an increase in
interest in the use of so-called non-invasive
brain stimulation to treat EDs. These tech-
niques, principally transcranial magnetic
stimulation (TMS) and transcranial direct
current stimulation (tDCS), use magnetic
or electric fields to transfer energy across
the skull, and so to modulate neural activ-
ity. Here, we explore the rationale for using
TMS/tDCS in EDs, and argue that many
ethical and safety issues must be clari-
fied before widespread adoption of these
techniques is possible.
TRANSCRANIAL STIMULATION IN EDs
Transcranial magnetic stimulation uses
pulsed magnetic fields, which cross the
skull and generate electrical effects in
nerve cells in the cortex. Two variants of
TMS are most likely to show promise in
EDs: repetitive TMS (rTMS) uses trains of
pulses spaced at 1 Hz, and typically has an
inhibitory effect on the brain area being
targeted (Rossi et al., 2009); the related
technique of theta-burst TMS delivers the
pulses more rapidly and in clusters, with
the effect on brain tissue being excitatory
or inhibitory depending on the parameters
used (Huang et al., 2005). tDCS uses small
electric currents that cross the skull and
induce electric fields on the cortical surface.
These fields alter the excitability of the neu-
rons close to the electrodes, with cells close
to the positive electrode (anode) becom-
ing slightly more excitable and those near
the negative electrode (cathode) reducing
in activity. Collectively, these techniques
are often referred to as non-invasive brain
stimulation, although we have argued that
the term “non-invasive” may be inaccurate,
and misleading to naïve participants (Davis
and van Koningsbruggen, 2013).
Brain imaging has allowed a greater
understanding of the neural mechanisms
of different EDs to be developed (Kaye
et al., 2009; Schäfer et al., 2010). For
instance, fMRI studies have found that
individuals with AN often have abnor-
malities in frontal and subcortical areas
involved in processing reward learning
(Celone et al., 2011). The parietal cortex
has also been implicated in maintaining a
normal representation of the body (Boghi
et al., 2011). The discovery of differences in
brain processes between healthy people and
those with EDs motivates the use of TMS
and tDCS to target cortical regions that
may be under- or over-active in EDs. For
example, in one study, rTMS over the left
dorsolateral prefrontal cortex (DLPFC) in
AN patients resulted in reductions in feel-
ing fat and full and in anxiety, but had little
impact on mood, tension, or urge to exer-
cise (Van den Eynde et al., 2013). In another
study, two people with AN received rTMS
to left DLPFC and showed a reduction
in symptoms for a short while, although
their weight and BMI had worsened on
follow-up (McClelland et al., 2013).
However, although brain imaging stud-
ies have afforded a better understanding
of the neural underpinnings of EDs, our
knowledge is still fairly limited and this
raises the ethical question about how to jus-
tify targeting a specific region for different
EDs, when there is little concrete evidence
that those regions are definitively involved
(Illes et al., 2006).
SAFETY AND DOSAGE OF
TRANSCRANIAL STIMULATION
Transcranial magnetic stimulation and
tDCS are relatively safe interventions when
used in healthy people and within known
safety limits. Known side-effects include
headache, mild hearing effects, and skin
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tenderness. In more serious cases, there
may be changes in cortical excitability lead-
ing to seizure or to mood changes. Within
the established limits of 2 mA for tDCS or
1000 pulses for TMS, these serious side-
effects are rare (Bikson et al., 2009; Rossi
et al., 2009; Davis et al., 2013). There is
however a considerable gap in our knowl-
edge of how TMS and tDCS exert an effect
on the brain given a certain level of stim-
ulation, or to put it another way, there is
no principled method for setting dosage in
TMS/tDCS.
At present, the best method for estimat-
ing in advance the appropriate dosage of
stimulation to deliver to a person is to cre-
ate a computational model of the person’s
head tissue, and to calculate the transmis-
sion of electric or magnetic energy through
the different tissue types to a target brain
area. These models may also aid in posi-
tioning the electrodes or coil for better
targeting. For example, modeling of the
electric field during tDCS has been used to
determine the optimal electrode montage
to treat the pain of fibromyalgia (Men-
donca et al., 2011), and related approaches
have been used to estimate how to set
dosage in TMS given variability in scalp-to-
cortex distance (Stokes et al., 2005). These
approaches are costly and time-consuming
since they require access to an MRI facility
to scan the person’s head tissue, and finite-
element modeling experience to create the
head model, and are therefore rarely used in
tDCS research as it is often sufficient to use
an anatomical landmark for positioning
(e.g., Koessler et al., 2009). Recently, some
packages have been developed that auto-
mate some of these processes (e.g., Truong
et al., 2014). Frequently, these packages use
a “standard” head model to be representa-
tive of a “normal” adult head. We would
urge caution in generalizing these models
to people with EDs.
Eating disorders are typically a disor-
der of young adulthood (Hoek and van
Hoeken, 2003; Hudson et al., 2007). We
have previously noted that stimulation pro-
tocols that are effective and tolerable in
adults may not necessarily be safe or tolera-
ble in younger people (Davis, 2014). There
are qualitative differences in the head tis-
sue of younger people that make the stan-
dard models inapplicable. Specifically, the
smaller size of the head and the more effi-
cient flow of current across the skull mean
that a specific dose of stimulation will have
a larger effect on the brain of a child than it
will on the brain of an adult (Kessler et al.,
2013).
As well as the problems of stimulating
dosage in younger people, people with EDs
present additional challenges. Fat deposits
in the head add to the insulating qualities of
the various tissue types, meaning that lower
levels of fat will lead to a higher transfer of
energy to the brain surface. A recent mod-
eling study suggested that excess fat due
to obesity made the tDCS-induced elec-
tric field less easy to predict (Truong et al.,
2013); however, the equivalent study for
lower-than-normal cutaneous fat has not
been performed. It is also worth noting that
demineralized bone has greater electrical
permittivity than normal bone, suggesting
that stimulation transfer is more efficient in
people with a less mineral-rich diet (Ivan-
cich et al., 1992). A further problem that
complicates the use of standardized head
models is the altered cortical folding in
people with EDs. People with BN show
characteristic patterns of enlargements and
deformations of cortical areas, particularly
around the prefrontal cortex and the occip-
ital pole (Marsh et al., in press). These mor-
phological differences mean that TMS is
more or less effective in these areas (Stokes
et al., 2005), or that the tDCS-induced field
is distributed differently (Miranda et al.,
2006). Taken together, these differences
between the head tissue of healthy people
and people with EDs imply that clinicians
and researchers should exercise caution in
setting the dose of any TMS/tDCS-based
intervention.
In addition to the above factors, it
should be noted that the efficacy of brain
stimulation is frequently state-dependent
(e.g., Silvanto et al., 2008). The brain
responds rapidly to the person’s nutritional
state (Streitburger et al., 2012). Studies ana-
lyzing brain morphology in EDs require
careful control of the person’s nutritional
state in order to make group compar-
isons (e.g., Frank et al., 2013a,b). We
therefore recommend that future studies
involving people with EDs should con-
trol and report the nutritional state of the
participants. Future clinical applications
of TMS/tDCS should also be mindful of
the state-dependence of brain stimulation,
which may include medicative state as well
as nutritative (Davis et al., 2013).
ETHICAL ISSUES IN TREATING EDs
A recent article explored the ethical issues
involved in brain stimulation treatments
for AN (Coman et al., 2014). They
focused on the principles of beneficence
(equivalent to efficacy of treatment), non-
maleficence (avoidance of side-effects),
respect for autonomy (informed consent
and capacity for consent), and justice (fair
access to treatment). Of these principles,
beneficence is the least easy to assess due to
the small number of studies that have been
reported in this area; however, there appear
to be grounds for optimism. Importantly,
researchers and clinicians should adhere to
good research practices in developing well-
controlled experiments and in reporting all
experimental results (Davis et al., 2013).
A complicating factor in assessing efficacy
is the ethical problem of including a no-
treatment group in any trial, where doing
nothing may seriously imperil the health
of the patient. Access to treatment is not
currently a pressing issue, as the necessary
equipment is confined to specialist labs and
clinics; however, if the techniques become
more widespread there may arise the need
for clear guidelines to prioritize treatment
for those with most to gain. However, a
related issue is the balance between pro-
tecting individual rights, and developing
and testing treatments for the good of
a wider population; although there is no
clear answer to this dilemma, we can at
least ensure that individuals understand the
different levels of risks and benefits before
enrolling in a trial. As a guiding princi-
ple, we argue that the safety of vulnera-
ble participants should be paramount, and
that trials and treatments should minimize
both the number of participants (while still
retaining statistical power) and the dose
delivered to each participant (Davis et al.,
2013).
Non-maleficence should be the overrid-
ing concern of any clinician when prescrib-
ing a treatment. This article is an attempt to
enumerate a number of factors that make
it difficult to assess safety, and therefore,
maleficence, in relation to TMS/tDCS in
people with EDs. We therefore suggest that
it is a clinician’s and an experimenter’s duty
to critically evaluate the published reports
of TMS/tDCS in EDs to judge the safety of a
technique in relation to a particular patient.
The gaps in our knowledge about the effects
and side-effects of stimulation mean that a
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person’s ability to give fully informed con-
sent to treatment is limited by the clinician’s
own knowledge. This and other factors
related to assumptions about the ability
of a person with ED to hold the capacity
for informed consent (Blinder et al., 2006;
Abbate-Dago et al., 2013; Coman et al.,
2014), mean that particular care must be
taken to respect the autonomy of a person
considered for treatment with TMS/tDCS.
CONCLUSION
In this paper, we have argued that treat-
ment of EDs with transcranial stimula-
tion introduces a number of ethical and
safety issues that require some examina-
tion. These issues are all the more pressing
given the rise in awareness and availabil-
ity of brain stimulation to lay people. For
example, it is possible to build an elec-
tronic circuit to deliver tDCS for very lit-
tle cost, which has given rise to a move-
ment in so-called “DIY-tDCS” (Fitz and
Reiner, 2013). We as researchers and clin-
icians therefore have a duty to deal hon-
estly with the technical and ethical prob-
lems that arise in a rapidly developing
field.
We have identified a number of key
questions about TMS/tDCS that should be
addressed. Primarily, it will be crucial to
understand how to set the appropriate dose
of stimulation for a given patient, brain tar-
get, and desired effect. This is true for all
brain stimulation, but particularly in the
case of people with EDs who may have
qualitative differences in anatomy com-
pared to healthy people. It is likely that
individual MRI-derived head models will
prove to be the most effective means of
dose-setting. We also suggest that clinicians
and researchers are encouraged to report
fully the results of every trial. This is an
element of good scientific practice that is
difficult to police; however, the benefits are
clear in terms of reducing wasted time and
resources in repeating trials, and in mini-
mizing exposure of patients to potentially
harmful treatments (Davis et al., 2013).
We recommend that scientists and clini-
cians proceed cautiously when designing
protocols, and do not translate protocols
designed for use in healthy adults directly to
use in people who are younger or who may
have altered cranial anatomy. If MRI-based
modeling is not available, we recommend
reducing stimulation intensity for use in
people with EDs.
The relative cheapness and the safety
of brain stimulation techniques such as
TMS and tDCS make it likely that they
will continue to develop as standalone or
adjunctive treatments for people with EDs.
We argue that wider use of these treat-
ments must be combined with a deeper
understanding both of the neurophysio-
logical mechanisms of the stimulation, and
of the neural bases of the disorders them-
selves. We are optimistic that brain stimula-
tion will be of great benefit to people who
suffer from these elusive and devastating
disorders.
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